Primary percutaneous transluminal coronary angioplasty in the setting of multivessel disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Myocardial Infarction Management

Background:

• Current guidelines recommend primary percutaneous coronary intervention (PCI) for the culprit lesion in acute myocardial infarction (AMI).
• Treatment of severe non-culprit lesions during primary PCI is generally not indicated (Class III indication).

Observation:

• The study presents two clinical cases where intervention on severe non-culprit lesions was performed alongside primary PCI.
• These cases explore the potential benefits of a more aggressive revascularization strategy.

Findings:

• Initial treatment of severe non-culprit lesions, in addition to the primary PCI of the culprit lesion, may reduce the incidence of delayed occlusions.
• This approach could be beneficial in specific clinical scenarios beyond current guideline recommendations.

Implications:

• Findings suggest a potential need to reconsider current guidelines regarding non-culprit lesion treatment in AMI.
• Further research into aggressive revascularization strategies for non-culprit lesions in specific AMI settings is warranted.
• These cases highlight a potential alternative management pathway for complex coronary artery disease presenting as AMI.